Skip to main content

Table 1 Baseline characteristics of the women and men with and without anemia

From: Prevalence and predictive importance of anemia in Swedish nursing home residents – a longitudinal study

Women
Parameter All (n = 276) Anemia (A) = Hb < 120 g/L (n = 89) Nonanemic (NA) (n = 187) p-value (A vs. NA)
  100% 32.2% 67.8%  
 Age (years) mean ± SD 85.9 ± 6.6 87.1 ± 6.0 85.4 ± 6.8 0.037
 Hb (g/L) mean ± SD 124.5 ± 13.6 109.0 ± 7.5 131.8 ± 8.7 <0.001
 Weight (kg) mean ± SD 63.9 ± 14.0 62.0 ± 13.7 64.7 ± 14.1 0.137
 Height (cm) mean ± SD 159.6 ± 6.8 159.0 ± 6.5 159.8 ± 6.9 0.370
 BMI (kg/m2) mean ± SD 25.0 ± 5.0 24.6 ± 5.2 25.3 ± 5.0 0.296
 Physical activity (h/week) mean ± SD 0.51 ± 0.76 0.43 ± 0.69 0.54 ± 0.79 0.246
 Social activity (h/week) mean ± SD 1.97 ± 2.32 1.97 ± 2,28 1.97 ± 2,34 0.983
 Medications in total ± SD 6.8 ± 3.0 7.0 ± 3,3 6.7 ± 2,9 0.442
 Warfarin 7.2% (n = 20) 3.4% (n = 3) 9.1% (n = 17) 0.087
 ASA 50.7% (n = 140) 46.1% (n = 41) 52.9% (n = 99) 0.286
 SSRI 35.1% (n = 97) 39.3% (n = 35) 33.2% (n = 62) 0.316
 NSAID 1.8% (n = 5) 1.1% (n = 1) 2.1% (n = 4) 0.554
 BNP > 100 ng/L (n = 273) 50.5% 55.7% 48.1% 0.242
 eGFR < 60 mL/min (n = 273) 61,9% 67.4% 59.2% 0.192
 eGFR < 30 mL/min (n = 273) 7.0% 11.2% 4.9% 0.053
 Transthyretin < 0.23 g/L (n = 272) 59.9% 68.5% 55.7% 0.043
 CRP ≥ 10 mg/L (n = 275) 31.6% 46.6% 24.6% <0.001
 Ferritin > 204 μg/L (n = 276) 17.8% 25.8% 13.9% 0.015
 Transferrin < 1.9 g/L (n = 275) 4.7% 6.8% 3.7% 0.262
Men
Parameter All (n = 114) Anemia (A) = Hb < 130 g/l (n = 59) Nonanemic (NA) (n = 55) p-value (A vs NA)
  100% 51.8% 48.2%  
 Age (years) mean ± SD 83.0 ± 6.7 84.2 ± 6.3 81.8 ± 7.0 0.064
 Hb (g/L) mean ± SD 128.6 ± 15.4 117.1 ± 9.0 140.9 ± 10.6 <0.001
 Weight (kg) mean ± SD 73.9 ± 13.1 71.9 ± 11.9 76.0 ± 14.0 0.095
 Height (cm) mean ± SD 173 ± 6.7 172.4 ± 6.6 172.7 ± 6.9 0.811
 BMI (kg/m2) mean ± SD 24.8 ± 4.3 24.2 ± 4.1 25.4 ± 4.3 0.129
 Physical activity (h/week) mean ± SD (n = 109) 0.58 ± 0.94 0.39 ± 0.71 0.78 ± 1.11 0.030
 Social activity (h/week) mean ± SD (n = 109) 1.19 ± 1.94 1.04 ± 1.98 1.35 ± 1.89 0.401
 Medications in total 7.1 ± 3.2 7.6 ± 3,3 6.6 ± 3,0 0.078
 Warfarin 11.3% (n = 13) 11.7% (n = 7) 10.9% (n = 6) 0.873
 ASA 56.1% (n = 64) 52.5% (n = 31) 60.0% (n = 33) 0.423
 SSRI 33.3% (n = 38) 30.5% (n = 18) 36.4% (n = 20) 0.508
 NSAID 0.9% (n = 1) 1.7% (n = 1) 0.0% (n = 0) 0.332
 BNP > 100 ng/L (n = 113) 49.6% 63.8% 34.5% 0.002
 eGFR < 60 mL/min (n = 114) 61.4% 67.9% 54.5% 0.146
 eGFR < 30 mL/min (n = 114) 11.4% 20.3% 1.8% 0.002
 Transthyretin < 0.23 g/L (n = 114) 56.1% 62.7% 49.1% 0.143
 CRP ≥ 10 mg/L (n = 112) 34.8% 45.8% 22.6% 0.010
 Ferritin > 275 μg/L (n = 113) 15.0% 16.9% 13.0% 0.554
 Transferrin < 1.9 g/L (n = 113) 3.5% 3.4% 3.7% 0.928
  1. Hb hemoglobin, SD standard deviation, BMI Body Mass Index, ASA acetylsalicylic acid, SSRI selective serotonin re-uptake inhibitors, NSAID nonsteroidal anti-inflammatory drugs, BNP B-type natriuretic peptide, eGFR estimated glomerular filtration rate, CRP C-reactive protein